Alzheimer’s blood test promises detection years before symptoms develop

Amyloid beta deposits, or plaques, in the brain are the most commonly hypothesized causative agent behind Alzheimer’s disease. A new breakthrough blood test, developed by an international team of scientists, can reportedly measure the concentration of these amyloid beta concentrations using just a tiny blood sample.

Solution News Source

Alzheimer’s blood test promises detection years before symptoms develop

Amyloid beta deposits, or plaques, in the brain are the most commonly hypothesized causative agent behind Alzheimer’s disease. A new breakthrough blood test, developed by an international team of scientists, can reportedly measure the concentration of these amyloid beta concentrations using just a tiny blood sample.

Solution News Source

SIGN UP

TO GET A Free DAILY DOSE OF OPTIMISM


We respect your privacy and take protecting it seriously. Privacy Policy